Here, through an integrative targeted metabolomics assay and gene expression profiling, we showed that FDXR promoted fatty acid oxidation (FAO) by positively regulating CPT1A expression and illustrated that the FDXR-CPT1A-FAO axis was responsible for primary and endocrine-resistant breast cancer cell growth. Here, CPT1A is linked to breast cancer.